YOLFTbeta
Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc

TMO · NYSE · Healthcare / Diagnostics & Research

700.22USD+0.78 (+0.11%)

Price History

Full chart

Market Stats

Previous Close699.44
Open701.42
Day Range689.71 – 702.03
52-Week Range434.50 – 705.79
Volume1.84M
Market Cap249.14B
P/E (TTM)35.54
Forward P/E23.92
EPS18.96
Dividend Yield0.28%
Beta0.88
50-Day Avg644.96
200-Day Avg549.28

About

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOMr. Marc N. Casper
  • Employees125.00K
  • Headquarters168 Third Avenue, Waltham, MA, United States, 02451, USA
  • Websitehttps://www.thermofisher.com

Leadership

  • Mr. Marc N. CasperChairman & CEO · b. 1968
  • Mr. Gianluca PettitiPresident, COO & President of Products and Technologies · b. 1979
  • Mr. James R. MeyerSenior VP & CFO · b. 1979
  • Mr. Joseph R. HolmesVP & Chief Accounting Officer · b. 1980
  • Mr. Ryan J. SnyderSenior VP & Chief Information Officer
  • Dr. Karen E. Nelson Ph.D.Chief Scientific Officer
  • Mr. Rafael TejadaVice President of Investor Relations
  • Mr. Thomas Bailey Shropshire Jr.Senior VP and General Counsel
  • Ms. Sandy B. PoundVP & Chief Communications Officer
  • Mr. Alan J. MalusSenior Vice President of Strategy & Corporate Development · b. 1960

Financials

Income Statement

Currency: USD1986-12-311987-12-311988-12-311989-12-311990-12-311991-12-311992-12-311993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue331.60M383.40M500.60M579.00M708.00M805.50M949.00M1.25B1.59B2.21B2.93B3.56B3.87B2.47B2.28B2.19B2.09B2.10B2.21B2.63B3.79B9.75B10.50B10.11B10.79B11.73B12.51B13.09B16.89B16.97B18.27B20.92B24.36B25.54B32.22B39.21B44.91B42.86B42.88B44.56B
Growth (%)-+15.62%+30.57%+15.66%+22.28%+13.77%+17.82%+31.69%+26.85%+39.24%+32.85%+21.34%+8.69%-36.11%-7.72%-4.05%-4.65%+0.52%+5.19%+19.36%+44.00%+157.05%+7.71%-3.70%+6.72%+8.69%+6.69%+4.64%+29.02%+0.45%+7.71%+14.47%+16.45%+4.86%+26.14%+21.71%+14.55%-4.58%+0.05%+3.91%
Cost of Revenue219.30M248.70M325.70M384.10M443.00M510.20M579.80M713.10M866.30M1.12B1.54B1.84B2.02B1.26B1.26B1.23B1.16B1.15B1.19B1.40B2.10B5.85B6.26B6.04B6.12B6.69B7.10B7.46B9.00B9.13B9.69B11.24B13.37B14.20B16.19B19.58B25.90B25.30B25.15B26.32B
Gross Profit112.30M134.70M174.90M194.90M265.00M295.30M369.20M536.60M719.00M1.08B1.39B1.72B1.84B1.21B1.02B958.62M927.38M948.01M1.02B1.24B1.69B3.89B4.24B4.07B4.27B4.87B5.41B5.63B7.89B7.84B8.58B9.68B10.99B11.34B16.03B19.63B19.01B17.56B17.73B18.24B
Gross Margin33.87%35.13%34.94%33.66%37.43%36.66%38.90%42.94%45.35%49.05%47.40%48.36%47.65%48.81%44.81%43.81%44.45%45.21%46.04%47.00%44.49%39.95%40.41%40.26%39.62%41.50%43.28%42.98%46.69%46.20%46.96%46.27%45.11%44.41%49.75%50.07%42.33%40.98%41.34%40.93%
Operating Expense100.00M127.20M155.70M177.10M229.40M257.00M300.90M413.00M539.20M835.40M1.11B1.31B1.47B957.70M823.68M924.42M771.92M763.24M761.14M943.68M1.32B2.83B2.98B2.95B3.01B3.39B3.79B3.83B5.54B5.34B5.72B6.41B7.12B7.08B8.13B9.32B10.49B10.70B10.07B10.13B
Operating Income12.30M7.50M19.20M17.80M35.60M38.30M68.30M123.60M179.80M247.30M284.20M407.00M375.80M248.60M198.16M34.20M155.45M184.77M254.44M293.77M365.30M1.07B1.27B1.12B1.26B1.48B1.63B1.80B2.35B2.49B2.86B3.27B3.87B4.26B7.90B10.32B8.53B6.86B7.66B8.11B
Operating Margin3.71%1.96%3.84%3.07%5.03%4.75%7.20%9.89%11.34%11.20%9.69%11.44%9.72%10.06%8.69%1.56%7.45%8.81%11.53%11.16%9.63%10.94%12.06%11.06%11.72%12.63%13.02%13.74%13.90%14.70%15.64%15.62%15.90%16.67%24.51%26.31%18.98%16.00%17.87%18.20%
EBITDA20.70M17.60M30.30M30.50M54.40M61.70M97.50M166.00M242.10M332.30M399.40M371.60M353.40M362.20M295.65M265.43M193.08M279.30M336.34M435.88M502.07M1.78B2.07B1.83B1.92B2.18B2.49B2.58B4.25B4.04B4.25B5.05B6.20B7.02B10.11B11.97B11.94B6.86B11.80B11.47B
EBITDA Margin6.24%4.59%6.05%5.27%7.68%7.66%10.27%13.28%15.27%15.05%13.62%10.44%9.14%14.66%12.96%12.13%9.25%13.32%15.25%16.55%13.24%18.24%19.74%18.13%17.78%18.63%19.94%19.72%25.17%23.81%23.27%24.16%25.44%27.50%31.37%30.52%26.59%16.00%27.52%25.73%
Net Income14.30M18.10M20.10M24.60M33.90M47.10M59.20M76.60M103.40M140.10M190.80M239.30M181.90M-174.60M-36.11M-781.00K309.73M200.01M361.84M223.22M168.94M761.10M994.20M850.30M1.04B1.33B1.18B1.27B1.89B1.98B2.02B2.23B2.94B3.70B6.38B7.72B6.95B6.00B6.33B6.74B
Net Income Margin4.31%4.72%4.02%4.25%4.79%5.85%6.24%6.13%6.52%6.35%6.51%6.73%4.70%-7.07%-1.58%-0.04%14.85%9.54%16.40%8.48%4.46%7.81%9.47%8.41%9.60%11.34%9.42%9.73%11.22%11.64%11.06%10.64%12.06%14.47%19.79%19.70%15.47%13.99%14.77%15.12%
R&D--------103.70M269.60M301.00M337.30M367.30M171.10M176.76M171.61M155.12M146.39M134.68M152.78M170.18M238.70M249.10M246.10M284.40M340.20M376.40M395.50M691.10M692.30M754.80M888.00M967.00M1.00B1.18B1.41B1.47B1.34B1.39B1.40B
R&D as % of Total Revenue--------6.54%12.21%10.26%9.48%9.50%6.92%7.75%7.84%7.44%6.98%6.11%5.80%4.49%2.45%2.37%2.43%2.64%2.90%3.01%3.02%4.09%4.08%4.13%4.25%3.97%3.93%3.67%3.59%3.28%3.12%3.24%3.14%
Interest Expense--------000000000010.98M26.71M51.93M139.80M129.90M118.10M84.70M191.80M241.60M262.30M479.90M414.90M469.60M592.00M667.00M676.00M553.00M536.00M726.00M1.38B1.65B1.42B
Interest Expense % of Total Revenue--------0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.50%1.01%1.37%1.43%1.24%1.17%0.79%1.64%1.93%2.00%2.84%2.45%2.57%2.83%2.74%2.65%1.72%1.37%1.62%3.21%3.86%3.18%

Balance Sheet

Currency: USD1986-12-311987-12-311988-12-311989-12-311990-12-311991-12-311992-12-311993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets308.90M426.10M490.10M623.60M898.20M1.20B1.82B2.47B3.02B3.74B5.14B5.80B6.33B5.18B4.86B3.83B3.65B3.39B3.58B4.25B21.26B21.21B21.09B21.60B21.39B26.83B27.44B31.86B42.85B40.83B45.91B56.67B56.23B58.38B69.05B95.12B97.15B98.73B97.32B110.34B
Total Liabilities163.10M264.30M308.60M361.40M498.40M590.50M1.10B1.32B1.70B1.96B2.63B2.99B3.34B2.80B2.30B1.91B1.61B1.01B911.17M1.46B7.35B6.72B6.16B6.17B6.03B11.80B11.98B15.01B22.30B19.48B24.37B31.26B28.65B28.71B34.53B54.15B53.01B51.88B47.65B56.81B
Total Equity145.80M161.80M181.50M210.60M315.90M486.50M558.40M873.00M990.30M1.30B1.75B2.00B2.25B2.01B2.53B1.91B2.03B2.38B2.67B2.79B13.91B14.49B14.93B15.43B15.36B15.04B15.46B16.86B20.55B21.35B21.54B25.41B27.59B29.68B34.51B40.79B43.98B46.73B49.58B53.41B
Cash63.80M144.10M136.40M93.90M117.90M131.00M190.60M325.70M382.80M462.00M414.00M594.00M397.00M282.00M506.00M298.00M339.04M303.91M326.89M214.33M667.43M625.10M1.28B1.56B917.10M1.02B805.60M5.83B1.34B452.10M786.00M1.33B2.10B2.40B10.32B4.48B8.52B8.08B4.02B9.85B
Total Debt62.90M141.00M159.80M199.60M216.80M259.90M516.20M693.40M1.13B1.22B1.70B1.92B2.16B1.68B1.61B787.00M935.82M275.49M241.09M598.77M2.66B2.20B2.06B2.18B2.14B7.03B7.12B10.49B14.56B12.47B16.63B21.01B18.99B18.49B22.55B36.34B36.07B36.42B32.77B39.38B
Net Debt-900.00K-3.10M23.40M105.70M98.90M128.90M325.60M367.70M750.00M760.00M1.29B1.33B1.76B1.40B1.10B489.00M596.78M-28.42M-85.80M384.44M2.00B1.57B777.80M619.30M-811.30M6.01B6.27B4.61B13.22B12.02B15.84B19.65B16.88B16.07B12.22B31.86B27.55B28.34B28.77B29.53B

Cash Flow

Currency: USD1989-12-311990-12-311991-12-311992-12-311993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow47.60M18.60M23.00M54.90M126.70M204.20M194.60M224.50M269.00M328.50M337.12M199.92M188.40M102.89M216.72M264.51M270.91M405.65M1.48B1.42B1.66B1.50B1.69B2.04B2.01B2.62B2.82B3.16B4.00B4.54B4.97B8.29B9.54B9.15B8.41B8.67B7.82B
Investing Cash Flow-96.60M-76.00M-278.40M-410.60M-399.30M-450.00M-382.00M-1.31B-319.80M-632.30M-73.60M229.58M176.16M508.48M378.79M34.15M-753.48M283.45M-586.00M-450.00M-829.50M-858.90M-5.14B-1.33B-263.30M-11.78B-1.09B-5.53B-7.73B-1.25B-1.49B-1.51B-21.93B-2.16B-5.14B-5.84B-4.05B
Financing Cash Flow87.20M75.90M270.60M417.70M411.10M300.90M263.20M1.04B237.80M102.20M-286.90M-137.58M-696.31M-592.97M-665.61M-183.22M390.86M-260.10M-928.70M-228.40M-557.50M-1.30B3.55B-917.70M3.31B4.80B-2.62B2.86B3.85B-2.24B-3.12B959.00M6.58B-2.81B-3.62B-6.79B1.80B
Capital Expenditure47.90M120.00M33.50M60.00M56.60M60.20M62.90M124.50M960.70M401.20M488.00M74.04M84.80M51.21M46.14M49.98M43.55M76.80M175.50M264.40M207.50M265.50M266.50M315.10M282.40M427.60M422.90M444.40M508.00M758.00M926.00M1.47B2.52B2.24B1.48B1.40B1.52B
Free Cash Flow-300.00K-101.40M-10.50M-5.10M70.10M144.00M131.70M100.00M-691.70M-72.70M-150.88M125.88M103.60M51.68M170.58M214.53M227.37M328.86M1.31B1.16B1.45B1.23B1.42B1.72B1.73B2.19B2.39B2.71B3.50B3.79B4.05B6.82B7.02B6.91B6.93B7.27B6.29B
Dividends Paid-600.00K------------------748.20M741.40M5.16B142.20M216.20M234.80M240.60M238.40M237.00M266.00M297.00M337.00M395.00M455.00M523.00M583.00M636.00M
FCF to OCF-0.63%-545.16%-45.65%-9.29%55.33%70.52%67.68%44.54%-257.14%-22.13%-44.76%62.97%54.99%50.23%78.71%81.10%83.93%81.07%88.17%81.38%87.49%82.27%84.24%84.55%85.96%83.68%84.99%85.92%87.32%83.31%81.38%82.22%73.56%75.50%82.41%83.85%80.49%
Dividend Paid to FCF--0.59%------------------51.54%60.16%362.41%8.25%12.51%10.71%10.05%8.79%6.78%7.03%7.34%4.94%5.63%6.58%7.55%8.02%10.11%

Earnings

Report DateNov 7, 1995Mar 12, 1996May 9, 1996Aug 8, 1996Nov 7, 1996Mar 12, 1997May 7, 1997Aug 7, 1997Nov 6, 1997Mar 4, 1998Jun 2, 1998Aug 12, 1998Nov 12, 1998Feb 24, 1999May 12, 1999Aug 12, 1999Nov 10, 1999Mar 2, 2000May 1, 2000Aug 3, 2000Oct 30, 2000Feb 14, 2001Apr 26, 2001Jul 26, 2001Oct 24, 2001Feb 13, 2002Apr 24, 2002Jul 23, 2002Oct 22, 2002Feb 5, 2003Apr 23, 2003Jul 22, 2003Oct 21, 2003Feb 4, 2004Apr 27, 2004Jul 27, 2004Oct 26, 2004Feb 2, 2005Apr 27, 2005Jul 27, 2005Oct 26, 2005Feb 1, 2006Apr 26, 2006Jul 26, 2006Oct 25, 2006Feb 8, 2007Apr 26, 2007Jul 26, 2007Oct 25, 2007Feb 6, 2008Apr 24, 2008Jul 24, 2008Oct 23, 2008Feb 4, 2009Apr 23, 2009Jul 23, 2009Oct 22, 2009Feb 3, 2010Apr 28, 2010Jul 27, 2010Oct 27, 2010Feb 2, 2011Apr 27, 2011Jul 27, 2011Oct 26, 2011Feb 1, 2012Apr 25, 2012Jul 25, 2012Oct 24, 2012Jan 31, 2013Apr 24, 2013Jul 24, 2013Oct 23, 2013Jan 30, 2014Apr 23, 2014Jul 23, 2014Oct 22, 2014Jan 29, 2015Apr 22, 2015Jul 22, 2015Oct 21, 2015Jan 28, 2016Apr 28, 2016Jul 28, 2016Oct 27, 2016Jan 31, 2017Apr 26, 2017Jul 26, 2017Oct 25, 2017Jan 31, 2018Apr 25, 2018Jul 25, 2018Oct 24, 2018Jan 30, 2019Apr 24, 2019Jul 24, 2019Oct 23, 2019Jan 30, 2020Apr 22, 2020Jul 22, 2020Oct 21, 2020Feb 1, 2021Apr 29, 2021Jul 28, 2021Oct 27, 2021Feb 2, 2022Apr 28, 2022Jul 28, 2022Oct 26, 2022Feb 1, 2023Apr 26, 2023Jul 26, 2023Oct 25, 2023Jan 31, 2024Apr 24, 2024Jul 24, 2024Oct 23, 2024Jan 30, 2025Apr 23, 2025Jul 23, 2025Oct 22, 2025Jan 29, 2026Apr 23, 2026Jul 23, 2026Oct 21, 2026Oct 28, 2026
EPS Estimate0.280.300.290.310.350.360.350.360.380.400.370.300.180.230.160.210.250.230.120.140.180.230.180.230.210.230.190.220.240.290.230.240.270.340.270.290.300.390.310.350.390.470.360.410.420.530.530.600.630.690.720.770.760.830.700.670.760.880.750.850.830.950.880.981.071.161.111.161.161.281.291.311.281.381.401.631.691.941.611.781.792.111.742.011.972.382.022.272.252.672.412.632.563.182.743.002.893.542.822.894.306.576.685.474.705.276.214.984.825.205.035.435.615.644.715.125.255.945.105.235.506.455.245.716.406.40
EPS Actual0.300.310.310.320.360.360.350.370.430.440.370.340.270.240.160.230.230.250.030.160.180.250.210.230.220.250.200.240.250.310.220.260.270.350.290.290.320.380.310.360.400.490.390.420.440.570.590.650.650.760.740.800.760.880.620.740.780.910.840.840.901.000.920.991.071.181.171.221.191.361.371.321.301.431.531.721.711.991.631.841.802.121.802.032.032.412.082.302.312.792.502.752.623.252.813.042.943.552.943.895.637.097.215.605.766.547.255.515.085.405.035.155.695.675.115.375.286.105.155.365.796.575.446.036.68-
Surprise7.14%3.33%6.90%3.23%2.86%0.00%0.00%2.78%13.16%10.00%0.00%13.33%50.00%4.35%0.00%9.52%-8.00%8.70%-75.00%14.29%0.00%8.70%16.67%0.00%4.76%8.70%5.26%9.09%4.17%6.90%-4.35%8.33%0.00%2.94%7.41%0.00%6.67%-2.56%0.00%2.86%2.56%4.26%8.33%2.44%4.76%7.55%11.32%8.33%3.17%10.14%2.78%3.90%0.00%6.02%-11.43%10.45%2.63%3.41%12.00%-1.18%8.43%5.26%4.55%1.02%0.00%1.72%5.41%5.17%2.59%6.25%6.20%0.76%1.56%3.62%9.29%5.52%1.18%2.58%1.24%3.37%0.56%0.47%3.45%0.99%3.05%1.26%2.97%1.32%2.67%4.49%3.73%4.56%2.34%2.20%2.55%1.33%1.73%0.28%4.26%34.60%30.93%7.91%7.93%2.38%22.55%24.10%16.75%10.64%5.39%3.85%0.00%-5.16%1.43%0.53%8.49%4.88%0.57%2.69%0.98%2.49%5.27%1.86%3.82%5.60%4.38%-
Timing-------Pre-marketPre-marketPre-marketPre-marketPre-marketPre-market-----------After-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-

Key Statistics & Ratios

Market Cap249.14B
Enterprise Value281.90B
Trailing P/E35.54
Forward P/E23.92
PEG Ratio1.96
Price / Sales5.26
Price / Book4.62
EPS18.96
Book Value148.02
Revenue (TTM)47.35B
Gross Profit (TTM)19.50B
EBITDA12.20B
Profit Margin14.94%
Operating Margin20.19%
Return on Equity13.38%
Return on Assets5.23%
Shares Outstanding369.75M
Shares Float369.07M
Beta0.88
Dividend Yield0.28%
Dividend Rate1.88
Payout Ratio6.03%

Analyst Ratings

Strong Buy
Based on 27 analystsTarget 750.92
  • Strong Buy
    20
  • Buy
    3
  • Hold
    3
  • Sell
    1

Ownership Breakdown

Institutions
94.00%
Insiders
0.13%
Retail / Other
5.87%

Top Institutional Holders

  • BlackRock Inc
    30.92M8.36%
  • Vanguard Capital Management, LLC
    24.28M6.57%
  • State Street Corp
    16.83M4.55%
  • FMR Inc
    14.08M3.81%
  • Morgan Stanley - Brokerage Accounts
    10.76M2.91%
  • JPMorgan Chase & Co
    8.50M2.30%
  • Geode Capital Management, LLC
    8.38M2.27%
  • Franklin Templeton Inc
    7.27M1.97%
  • Vanguard Portfolio Management, LLC
    6.23M1.68%
  • Capital World Investors
    6.20M1.68%
  • T. Rowe Price Associates, Inc.
    5.12M1.38%
  • NORGES BANK
    5.09M1.38%
  • Capital Research Global Investors
    4.15M1.12%
  • Bank of New York Mellon Corp
    3.94M1.07%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    11.74M3.17%
  • Vanguard 500 Index Investor
    9.71M2.63%
  • iShares Core S&P 500 ETF
    4.93M1.33%
  • Fidelity 500 Index
    4.82M1.30%
  • State Street® SPDR® S&P 500® ETF
    4.53M1.23%
  • Fidelity Contrafund
    4.12M1.12%

Dividends

20263×
0.47Sep 15, 20260.47Jun 15, 20260.47Mar 13, 2026
20254×
0.43Dec 15, 20250.43Sep 15, 20250.43Jun 13, 20250.43Mar 14, 2025
20244×
0.39Dec 13, 20240.39Sep 13, 20240.39Jun 14, 20240.39Mar 14, 2024
20234×
0.35Dec 14, 20230.35Sep 14, 20230.35Jun 14, 20230.35Mar 14, 2023
20224×
0.30Dec 14, 20220.30Sep 14, 20220.30Jun 14, 20220.30Mar 15, 2022
20214×
0.26Dec 14, 20210.26Sep 14, 20210.26Jun 14, 20210.26Mar 15, 2021
20201×
0.22Dec 14, 2020

Stock Splits

  • Jun 6, 19963:2
  • May 25, 19953:2
  • Oct 29, 19933:2